Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-259,402
Closed -$25.5M 1435
2025
Q2
$25.5M Buy
259,402
+2,755
+1% +$261K 0.18% 125
2025
Q1
$23.8M Sell
256,647
-144,737
-36% -$13.3M 0.22% 113
2024
Q4
$36.4M Buy
401,384
+137,838
+52% +$12.7M 0.31% 62
2024
Q3
$25.4M Sell
263,546
-122,012
-32% -$11.9M 0.2% 90
2024
Q2
$35.4M Buy
385,558
+199,367
+107% +$18.5M 0.3% 65
2024
Q1
$17.2M Buy
186,191
+179,624
+2,735% +$16.8M 0.17% 120
2023
Q4
$624K Buy
+6,567
New +$613K 0.01% 629
2020
Q4
Sell
-11,773
Closed -$2.78M 487
2020
Q3
$2.78M Sell
11,773
-2,078
-15% -$472K 0.06% 129
2020
Q2
$2.75M Buy
+13,851
New +$2.58M 0.07% 202
2015
Q4
Sell
-7,987
Closed -$303K 226
2015
Q3
$303K Buy
+7,987
New +$337K 0.03% 259

Other funds holding AMED

LMR Partners's AMED Position: Q3 2025 in Review

LMR Partners sold out of Amedisys (AMED) in Q3 2025, closing a stake of 259,402 shares — an estimated $25.5M sold.

LMR Partners first reported a position in AMED in Q3 2015 and held it in 10 quarters. The position peaked at $36.4M in Q4 2024. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • LMR Partners reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • LMR Partners sold 259,402 Amedisys shares in Q3 2025, an estimated $25.5M.
  • LMR Partners first reported a position in Amedisys in Q3 2015 and held it in 10 quarters.
  • LMR Partners's Amedisys position peaked at $36.4M in Q4 2024.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on LMR Partners's 13F filing for Q3 2025, filed 14 Nov 2025.